GNLX
Price
$2.94
Change
+$0.13 (+4.63%)
Updated
Nov 14 closing price
ROIV
Price
$11.64
Change
-$0.31 (-2.59%)
Updated
Nov 14 closing price
94 days until earnings call
Ad is loading...

GNLX vs ROIV

Header iconGNLX vs ROIV Comparison
Open Charts GNLX vs ROIVBanner chart's image
Genelux
Price$2.94
Change+$0.13 (+4.63%)
Volume$552.7K
CapitalizationN/A
Roivant Sciences
Price$11.64
Change-$0.31 (-2.59%)
Volume$5.43M
CapitalizationN/A
GNLX vs ROIV Comparison Chart
Loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GNLX vs. ROIV commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a Hold and ROIV is a StrongBuy.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (GNLX: $2.94 vs. ROIV: $11.64)
Brand notoriety: GNLX and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 358% vs. ROIV: 86%
Market capitalization -- GNLX: $101.53M vs. ROIV: $8.61B
GNLX [@Biotechnology] is valued at $101.53M. ROIV’s [@Biotechnology] market capitalization is $8.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 1 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 1 green, 4 red.
According to our system of comparison, ROIV is a better buy in the long-term than GNLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 3 TA indicator(s) are bullish while ROIV’s TA Score has 5 bullish TA indicator(s).

  • GNLX’s TA Score: 3 bullish, 4 bearish.
  • ROIV’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than GNLX.

Price Growth

GNLX (@Biotechnology) experienced а +1.03% price change this week, while ROIV (@Biotechnology) price change was -1.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

GNLX is expected to report earnings on Nov 14, 2024.

ROIV is expected to report earnings on Feb 17, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($8.61B) has a higher market cap than GNLX($102M). ROIV YTD gains are higher at: 3.651 vs. GNLX (-79.015).
GNLXROIVGNLX / ROIV
Capitalization102M8.61B1%
EBITDAN/AN/A-
Gain YTD-79.0153.651-2,164%
P/E RatioN/A2.03-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
GNLXROIV
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
61%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
60%
MACD
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
60%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 8 days ago
0%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
73%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
65%
View a ticker or compare two or three
Ad is loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

GNLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with VSTM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
+4.63%
VSTM - GNLX
48%
Loosely correlated
+0.73%
FHTX - GNLX
29%
Poorly correlated
-0.56%
SNSE - GNLX
29%
Poorly correlated
-13.06%
INSM - GNLX
27%
Poorly correlated
+0.93%
ROIV - GNLX
26%
Poorly correlated
-2.59%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-2.59%
IMVT - ROIV
58%
Loosely correlated
-2.94%
ARGX - ROIV
43%
Loosely correlated
-0.72%
FOLD - ROIV
42%
Loosely correlated
-2.70%
RARE - ROIV
41%
Loosely correlated
-2.20%
ABUS - ROIV
40%
Loosely correlated
-0.55%
More